Pricing Log in Create free account

DiaMedica Therapeutics, Inc. (DMAC) vs PureTech Health PLC Sponsored ADR (PRTCY)

DiaMedica Therapeutics, Inc. and PureTech Health PLC Sponsored ADR are both Biotechnology companies. DiaMedica Therapeutics, Inc. and PureTech Health PLC Sponsored ADR are of similar size ($433.6M and $424.0M). DiaMedica Therapeutics, Inc. has the higher net margin (0.00% vs −199.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 8 metrics below, DiaMedica Therapeutics, Inc. leads on 4 and PureTech Health PLC Sponsored ADR on 4.

Valuation

Metric DMAC PRTCY Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 10.68 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.81 0.64
EV/Sales n/m (9.10) 9.21
Earnings yield (9.47%) (1.48%) (33.15%)
Free cash flow yield (7.70%) 0.00% (25.50%)

Profitability

Metric DMAC PRTCY Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (199.36%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (114.62%) 0.00% (56.36%)
Return on assets (98.18%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DMAC PRTCY Biotechnology median
Revenue growth (TTM) — 28.48% 6.02%
EPS growth (last fiscal year) (16.67%) (2,277.05%) 30.26%
Revenue growth, 5-year CAGR — (16.92%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DMAC PRTCY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.72 6.59 4.72
Net debt to EBITDA 1.70 3.03 0.96

Dividend

Metric DMAC PRTCY Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DMAC PRTCY Biotechnology median
Market cap 433.56m 424.00m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack